Cargando…

6-[(18)F]Fluoro-L-DOPA and Cerebral Blood Flow in Unilaterally MPTP-Treated Monkeys

Intravenous administration of (15)O-labeled water and 6-[(18)F]-L-fluorodopa were used to assess abnormal striatal activity in monkeys after long-term recovery of unilateral lesions of the dopaminergic nigro-striatal system induced by the neurotoxin MPTP. PET data were examined in relation to behavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doudet, Doris J., Wyatt, Richard Jed, Cannon-Spoor, Eleanor, Suddath, Richard, McLellan, Catherine A., Cohen, Robert M.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565248/ https://www.ncbi.nlm.nih.gov/pubmed/7509198 http://dx.doi.org/10.1155/NP.1993.27

Ejemplares similares

Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
por: Fernagut, Pierre-Olivier, et al.
Publicado: (2010)

Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA
por: Neves, Ângela C. B., et al.
Publicado: (2021)

Correction to: Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA
por: Neves, Ângela C. B., et al.
Publicado: (2021)

AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys
por: Bourque, Mélanie, et al.
Publicado: (2022)

Improved GMP-compliant multi-dose production and quality control of 6-[(18)F]fluoro-L-DOPA
por: Luurtsema, G., et al.
Publicado: (2016)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2017)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
por: Zhao, Ting Ting, et al.
Publicado: (2017)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
por: Aron Badin, Romina, et al.
Publicado: (2013)

6-[(18)F]Fluoro-L-DOPA: A Well-Established Neurotracer with Expanding Application Spectrum and Strongly Improved Radiosyntheses
por: Pretze, M., et al.
Publicado: (2014)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
por: Aron Badin, Romina, et al.
Publicado: (2013)

Pancreatic uptake and radiation dosimetry of 6-[(18)F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism
por: Garg, Pradeep K., et al.
Publicado: (2017)

The Visual System (Report on Session 25.0)
por: Cannon-Spoor, H. Eleanor
Publicado: (1993)

GMP production of 6-[(18)F]Fluoro-l-DOPA for PET/CT imaging by different synthetic routes: a three center experience
por: Andersen, Valdemar L., et al.
Publicado: (2021)

Myocardial Metastases on 6-[(18)F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients
por: Noordzij, Walter, et al.
Publicado: (2014)

Alterations in Energy Metabolism, Neuroprotection and Visual Signal Transduction in the Retina of Parkinsonian, MPTP-Treated Monkeys
por: Campello, Laura, et al.
Publicado: (2013)

Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
por: Morin, Nicolas, et al.
Publicado: (2014)

Quantitative Behavioral Assessment Methods for the Analysis of Graft-Induced Motor and Cognitive Function in the MPTP-Treated Parkinsonian Monkey
por: Taylor, J. R., et al.
Publicado: (1992)

Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys
por: Ren, Zhenhua, et al.
Publicado: (2013)

Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys
por: Pifl, Christian, et al.
Publicado: (2017)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Orbitofrontal (18)F-DOPA Uptake and Movement Preparation in Parkinson's Disease
por: Marinelli, Lucio, et al.
Publicado: (2015)

L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)

Effects of L-DOPA on Gene Expression in the Frontal Cortex of Rats with Unilateral Lesions of Midbrain Dopaminergic Neurons
por: Radlicka, Anna, et al.
Publicado: (2021)

Normal biodistribution pattern and physiologic variants of (18)F-DOPA PET imaging
por: Chondrogiannis, Sotirios, et al.
Publicado: (2013)

Early Presymptomatic and Long-Term Changes of Rest Activity Cycles and Cognitive Behavior in a MPTP-Monkey Model of Parkinson's Disease
por: Vezoli, Julien, et al.
Publicado: (2011)

L-Dopa and Behavior
por: Kebabian, John
Publicado: (1974)

Effects of Photons Irradiation on (18)F-FET and (18)F-DOPA Uptake by T98G Glioblastoma Cells
por: Pasi, Francesca, et al.
Publicado: (2020)

Development of a unilateral ureteral obstruction model in cynomolgus monkeys
por: Huang, Linghong, et al.
Publicado: (2021)

Unilateral caudate inactivation increases motor impulsivity in rhesus monkeys
por: Eldridge, Mark A.G., et al.
Publicado: (2023)

Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
por: Pikstra, Angelina R.A., et al.
Publicado: (2016)

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study
por: Jauhar, Sameer, et al.
Publicado: (2018)

Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.
por: Jauhar, S, et al.
Publicado: (2017)

Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys
por: DiCaudo, Carla, et al.
Publicado: (2012)

Pilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys
por: Shi, Liangqin, et al.
Publicado: (2017)

Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson’s disease through AKT/mTOR pathway
por: Shi, Liangqin, et al.
Publicado: (2020)

Identifying the dataset to define the optimal timing of histopathological examination for central nervous system toxicity in MPTP-induced Parkinson’s disease monkey model
por: Yasuno, Hironobu, et al.
Publicado: (2023)

Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
por: Morissette, Marc, et al.
Publicado: (2022)

fMRI in Non-human Primate: A Review on Factors That Can Affect Interpretation and Dynamic Causal Modeling Application
por: Jovellar, D. Blair, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tjefdbukai8s937oam4sfpq2n6